Skip to main content

Strengthening Global Strategy & Collaboration: Insights from Our Executive Trip to Japan

We’d like to share highlights from our executive team’s recent trip to Japan! We had a productive week of strategic discussions with our parent company, focusing on the growth and innovation of our consumables and bulk business.

It was an invaluable opportunity to align on global strategies and explore new avenues for collaboration. A special shoutout to our CEO, Mark Dyment, for embracing the rich culture by participating in a beautiful and insightful traditional Japanese Tea Ceremony. A truly memorable experience!

We were also delighted to introduce Marc Jacob, PhD, our new Head of Strategic Development for Chromatography Products, to our esteemed colleagues in Japan. Welcome to the team, Marc! We’re excited to see your contributions as we drive our business forward together.

The meetings also included valuable contributions from Jeff Kakaley, Senior Manager of Sales and Applications, and J Preston, PhD,  Director of Separation Sciences. Their expertise and insights were crucial to our strategic discussions. It’s fantastic to see our diverse team come together to shape the future of our business.

We are especially grateful for the support of Kiyotaka Takimoto and his team for their application studies of both peptides and oligos using YMC resins and our Contichrom® TWIN Systems featuring MCSGP with AutoPeak® technology. Their work is instrumental in advancing our solutions and demonstrating efficacy.

This trip has reinforced our commitment to strengthening collaboration and fostering a global perspective. We’re eager to implement the strategic insights gained to better serve our customers worldwide.

 

Posted on April 3, 2025.

Related Posts

September 4, 2026

YMC America Brings U.S.-Supplied ASME U-Stamped DAC Columns to Pharmaceutical Manufacturers

YMC America will be the First U.S.-Based Supplier of ASME U-Stamped DAC Columns. The company’s DAC columns support pharmaceutical and biopharmaceutical customers from process development through commercial production. Systems are used in laboratory, pilot, and production-scale chromatography applications, including purification processes for peptides, oligonucleotides, and small-molecule APIs.

September 10, 2026

Analytical Technologies for Therapeutic Peptides

Therapeutic peptides are an emerging class of active pharmaceutical ingredients that, together with other classes of bioproducts, have been attracting considerable attention due to their unique advantages. Their structure is based on well-defined amino acid sequences that may or may not contain structural modifications, resulting in molecules that generally range from 500 to 5000 Da. Currently, many examples can be used as medicines related to hormones, growth factors, neurotransmitters, among others.

September 9, 2026

Tecnologias Analíticas para Peptídeos Terapêuticos- Portuguese

Os peptídeos terapêuticos são uma classe emergente de insumos farmacêuticos ativos que, juntamente com outras classes de bioprodutos, vêm despertando grande interesse devido às suas vantagens únicas.

Designed and developed by